Value of bone marrow biopsy in the diagnosis of essential thrombocythemia
AM Florena, C Tripodo, E Iannitto, R Porcasi… - …, 2004 - haematologica.org
BACKGROUND AND OBJECTIVES: Essential thrombocythemia (ET) is a Philadelphia
chromosome-negative chronic myeloproliferative disorder (CMPD) whose diagnosis …
chromosome-negative chronic myeloproliferative disorder (CMPD) whose diagnosis …
A long-term study of young patients with essential thrombocythemia treated with anagrelide
MG Mazzucconi, R Redi, S Bernasconi… - …, 2004 - haematologica.org
BACKGROUND AND OBJECTIVES: Essential thrombocythemia (ET) can be complicated by
life-threatening thrombosis and has a risk of converting into acute leukemia. Cytoreductive …
life-threatening thrombosis and has a risk of converting into acute leukemia. Cytoreductive …
[PDF][PDF] Contemporary issues in the fight against blood doping in sport
M Ashenden - Haematologica, 2004 - haematologica.org
One Olympic cycle has passed since international media and scientific scrutiny focused
upon breakthroughs in the fight to deter the widespread abuse of recombinant human …
upon breakthroughs in the fight to deter the widespread abuse of recombinant human …
PRV‐1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia
AM Vannucchi, A Grossi, A Pancrazzi… - British journal of …, 2004 - Wiley Online Library
Females with the monoclonal type of essential thrombocythaemia (ET), based on the X‐
chromosome inactivation pattern (XCIP), have previously been shown to present a higher …
chromosome inactivation pattern (XCIP), have previously been shown to present a higher …
Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia
M Doubek, Y Brychtova, R Doubek, P Janku… - Annals of …, 2004 - Springer
Platelet-lowering agents currently often used in essential thrombocythemia (ET) patients
with a high risk of developing thrombohemorrhagic complications include hydroxyurea …
with a high risk of developing thrombohemorrhagic complications include hydroxyurea …
Clinical Features of Chronic Myeloproliferative Disease
JM Kwon, SN Lee, KE Lee, SJ Yoon… - Korean Journal of …, 2004 - pesquisa.bvsalud.org
BACKGROUND: Philadephia chromosome negative chronic myeloproliferative disease
(CMPD) is a clonal disorder which includes polycythemia vera (PV), essential …
(CMPD) is a clonal disorder which includes polycythemia vera (PV), essential …
[PDF][PDF] Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices
M Cazzola - haematologica, 2004 - haematologica.org
The mechanism of action of anagrelide is still unclear, 10 and at least one study has shown
that its ability to prevent thrombosis in young patients is doubtful. 11 Therefore, it is at least …
that its ability to prevent thrombosis in young patients is doubtful. 11 Therefore, it is at least …
[引用][C] Anagrelide-induced visual hallucinations in a patient with essential thrombocythemia.
R Swords, M Fay, R O'Donnell… - European journal of …, 2004 - europepmc.org
Anagrelide-induced visual hallucinations in a patient with essential thrombocythemia. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[引用][C] Thrombotic and Bleeding Complications in Four Subpopulations of Patients with ET Defined by c-Mpl Protein Expression and PRV-1 mRNA Levels
PS Goerttler, E März, PL Johansson, B Andreasson…